Global Sinus Dilation Device (BSD, FESS Instruments Set) Markets Analysis & Forecasts, 2016-2020 & 2021-2028 -

DUBLIN--()--The "Global Sinus Dilation Device Market Size, Share & Trends Analysis Report by Product (BSD, FESS Instruments Set), by Procedure (Standalone, Hybrid), by Application (Pediatric, Adult), by End Use, and Segment Forecasts, 2021-2028" report has been added to's offering.

The global sinus dilation device market size is estimated to reach USD 4.6 billion by 2028, registering a CAGR of 11.0%

Changes in lifestyle, increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting the market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.

Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of health insurance and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.

In November 2017, Entellus Medical, Inc. announced that Anthem, Inc., an American health insurance company, provided insurance coverage for Balloon Sinus Dilation (BSD) used in the treatment of recurrent acute sinusitis and chronic sinusitis. Anthem, Inc. is a member of the Blue Cross Blue Shield Association, the second-largest health benefits plan provider that covers around 40 million people in the U.S.

Other major health insurance companies providing coverage for standalone BSD are Medicare, Aetna, Cigna, TRICARE, Humana, Health Net, Kaiser, and United Healthcare.

Sinus Dilation Device Market Report Highlights

  • The BSD devices segment held the largest revenue share in 2020 and will retain the leading position throughout the forecast period
  • The hybrid procedure segment led the market in 2020 and is also expected to register the fastest CAGR during the forecast period
  • Hybrid procedures are useful and effective in adults as well as pediatrics for the treatment of frontal chronic rhinosinusitis
  • The adult application segment held the largest market share in 2020 owing to the high prevalence of chronic rhinitis among the adult population
  • The hospitals end-use segment accounted for the highest share in 2020 owing to advanced infrastructure and an increasing number of patient visits in hospitals as compared to other healthcare facilities
  • North America is projected to account for the largest market share by 2028 due to the high adoption of novel technologies by ENT surgeons as well as other healthcare professionals in the region

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Sinus Dilation Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Penetration & Growth Prospect Mapping

3.3. Market Dynamics

3.3.1. Market driver analysis Favorable reimbursement scenario Technological advancements and new product launch Rising preference for minimally invasive surgical procedures

3.3.2. Market restraint analysis High adoption rate of alternative treatment

3.4. Sinus dilation devices Market Analysis Tools

3.4.1. Industry Analysis - Porter's

3.4.2. PESTEL analysis

3.4.3. Major deals & strategic alliances analysis

Chapter 4. Sinus Dilation Devices Market: By Product Estimates & Trend Analysis

4.1. Definitions and Scope

4.1.1. Balloon Sinus Dilation Devices

4.1.2. Endoscope Sinuscopes Rhinoscopes

4.1.3. Functional Endoscopic Instruments Set

4.1.4. Sinus Stents/Implants

4.1.5. Others

4.2. Product Market Share, 2021 & 2028

4.3. Segment Dashboard

4.4. Global Sinus Dilation Devices Market, by Product Outlook

4.4.1. Balloon Sinus Dilation Devices

4.4.2. Endoscope

4.4.3. Functional endoscopic sinus surgery instruments set

Chapter 5. Sinus Dilation Devices Market: By Procedure Estimates & Trend Analysis

5.1. Definitions and Scope

5.1.1. Standalone

5.1.2. Hybrid

5.2. Procedure Market Share, 2021 & 2028

5.3. Segment Dashboard

5.4. Global Sinus Dilation Devices Market, by Procedure Outlook

5.4.1. Standalone Standalone market estimates and forecast, 2016 - 2028 (USD Million)

5.4.2. Hybrid Hybrid market estimates and forecast, 2016 - 2028 (USD Million)

Chapter 6. Sinus Dilation Devices Market: By Application Estimates & Trend Analysis

6.1. Definitions and Scope

6.1.1. Adult

6.1.2. Pediatric

6.2. Application Market Share, 2021 & 2028

6.3. Segment Dashboard

6.4. Global Sinus Dilation Devices Market, by Application Outlook

6.4.1. Adult

6.4.2. Pediatric

Chapter 7. Sinus Dilation Devices Market: By End Use Estimates & Trend Analysis

7.1. Definitions and Scope

7.1.1. Hospitals

7.1.2. ENT Clinics/In Office

7.1.3. Ambulatory Surgical Centers

7.2. By End Use Market Share, 2021 & 2028

7.3. Segment Dashboard

7.4. Global Sinus Dilation Devices Market by End Use Outlook

7.4.1. Hospitals

7.4.2. ENT Clinics/In Office

7.4.3. Ambulatory surgical centers

Chapter 8. Sinus Dilation Devices Market: Country Estimates & Trend Analysis

8.1. Country Market Share Analysis, 2021 & 2028

8.2. County Market Dashboard

8.3. Regional Market Snapshot

8.4. Regional Market Share and Leading Players, 2020

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants

9.2. Company/Competition Categorization

9.2.1. Innovators

9.3. Vendor Landscape

  • Medtronic
  • Smith & Nephew plc
  • Entellus Medical, Inc.
  • Intersect ENT, Inc.
  • Olympus Corporation
  • Sinusys Corporation
  • Acclarent, Inc.
  • Creganna
  • InnAccel

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900